N1-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-N4-(8-(((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-8-oxooctyl)terephthalamide

ID: ALA5182303

Chembl Id: CHEMBL5182303

PubChem CID: 168274357

Max Phase: Preclinical

Molecular Formula: C53H66ClN7O7S

Molecular Weight: 980.67

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCNC(=O)c2ccc(C(=O)N[C@H]3C(C)(C)[C@H](Oc4ccc(C#N)c(Cl)c4)C3(C)C)cc2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C53H66ClN7O7S/c1-32-43(69-31-58-32)34-17-15-33(16-18-34)29-57-47(66)41-26-38(62)30-61(41)48(67)44(51(2,3)4)59-42(63)14-12-10-9-11-13-25-56-45(64)35-19-21-36(22-20-35)46(65)60-49-52(5,6)50(53(49,7)8)68-39-24-23-37(28-55)40(54)27-39/h15-24,27,31,38,41,44,49-50,62H,9-14,25-26,29-30H2,1-8H3,(H,56,64)(H,57,66)(H,59,63)(H,60,65)/t38-,41+,44-,49-,50-/m1/s1

Standard InChI Key:  OGHODJARGQMABV-XDARWKARSA-N

Alternative Forms

  1. Parent:

    ALA5182303

    ---

Associated Targets(Human)

AR Tclin VHL/Androgen receptor (497 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 980.67Molecular Weight (Monoisotopic): 979.4433AlogP: 8.14#Rotatable Bonds: 19
Polar Surface Area: 202.85Molecular Species: NEUTRALHBA: 10HBD: 5
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.71CX Basic pKa: 2.65CX LogP: 6.91CX LogD: 6.91
Aromatic Rings: 4Heavy Atoms: 69QED Weighted: 0.06Np Likeness Score: -0.52

References

1. Guo L, Zhou Y, Nie X, Zhang Z, Zhang Z, Li C, Wang T, Tang W..  (2022)  A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions.,  236  [PMID:35397401] [10.1016/j.ejmech.2022.114317]

Source